Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine infusion for postoperative analgesia in obstructive sleep apnea
ACTRN12609000731291Phase 4Completed
- Sponsor
- Dr. Walid Abd El Mageed Oncology Clinic
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Dr. Walid Abd El Mageed Oncology Clinic. Primary endpoints: postoperative visual analogue pain score and postoperative morphine consumption by patient-controlled analgesia. Started Jul 2007; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12609000731291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000731291.